CCSD Code T8700: Excision Biopsy of Lymph Node for Diagnosis

Key Takeaways

CCSD Code T8700 covers excision biopsy of a lymph node for diagnosis at cervical, inguinal, or axillary sites in UK private healthcare.

All major UK private insurers (Bupa, AXA Health, Allianz Care, The Exeter) reimburse T8700 based on the CCSD Schedule, but rates are contract-specific – always verify with the individual insurer before billing.

Pre-authorisation is required by most insurers before T8700 can proceed; submitting a claim without prior approval is the leading cause of denial for lymph node excision biopsy codes.

Pabau’s claims management software supports CCSD code submission via Healthcode, with structured patient records that capture the documentation insurers require for T8700 claims.

Claim denials for surgical biopsy codes in UK private healthcare rarely come down to incorrect coding. They come down to missing documentation, absent pre-authorisation references, or anaesthetic fees billed without checking bundling rules. CCSD Code T8700 – covering excision biopsy of a lymph node for diagnosis at cervical, inguinal, or axillary sites – is no exception. This guide covers exactly what billers and consultant surgeons need to submit clean T8700 claims across Bupa, AXA Health, Allianz Care, The Exeter, and other major UK private insurers.

T8700 sits within the CCSD Schedule of Procedures, which is maintained by the Clinical Coding and Schedule Development (CCSD) Group – the body responsible for developing and updating standardised procedure codes for UK private healthcare. Whether you work in a surgical day-case unit, a private oncology setting, or a general surgery clinic, understanding T8700’s clinical scope, insurer-specific requirements, and documentation standards will reduce rework and protect reimbursement. Providers looking to streamline their wider private billing should also review Pabau’s Bupa CCSD codes guide for broader context on how the schedule operates.

CCSD Code T8700: Definition and Clinical Description

CCSD Code T8700 is defined as: Excision biopsy of lymph node for diagnosis (cervical, inguinal or axillary). The procedure involves the surgical removal of an intact lymph node for histopathological examination, specifically at one of three anatomical sites – the cervical (neck), inguinal (groin), or axillary (armpit) regions.

This is a diagnostic procedure rather than a therapeutic one. The purpose is tissue analysis – most commonly to investigate unexplained lymphadenopathy, screen for lymphoma, or stage a known malignancy. Because the goal is intact node retrieval for pathological review, T8700 is distinct from fine needle aspiration (FNA) biopsy or core biopsy, which involve different CCSD codes and different clinical workflows.

According to the CCSD Technical Guide (October 2025), T8700 is used as an illustrative example within the biopsy coding rules section, confirming its status as an established, actively maintained code in the current schedule. The code appears within the general surgery and lymphatic system chapter, reflecting the procedure’s classification as a surgical excision biopsy rather than a purely diagnostic or imaging-guided intervention. Clinics using skin clinic software or surgical practice platforms should confirm their system maps T8700 correctly within the CCSD billing framework.

Applicable Clinical Scenarios

T8700 applies when a consultant surgeon excises an intact lymph node for diagnosis at one of the three listed sites. Common clinical indications include:

• Unexplained cervical, inguinal, or axillary lymphadenopathy not resolved by conservative measures
• Suspected lymphoma (Hodgkin or non-Hodgkin) requiring tissue for definitive diagnosis
• Investigation of metastatic disease with unknown primary site
• Staging workup where lymph node involvement needs histological confirmation
• Cases where FNA cytology has returned inconclusive results

T8700 does not apply to sentinel lymph node biopsy procedures (which carry a separate CCSD code) or to lymph node excisions performed as part of a wider cancer resection. The code is site-specific: only cervical, inguinal, and axillary locations are covered. Mediastinal, retroperitoneal, or pelvic lymph node excisions require different coding. Always verify with the current CCSD schedule before billing, as the schedule is updated periodically.

Which Insurers Reimburse T8700 and How

All major UK private medical insurers base their procedure fee schedules on the CCSD Schedule of Procedures. This means T8700 is a recognised, billable code across the UK private healthcare market. However, the reimbursement rate, bundling rules, and pre-authorisation requirements vary by insurer and by individual provider contract. The benefits of private practice billing only materialise when you understand each insurer’s specific rules.

Reimbursement rates are contract-specific and not published as fixed amounts by most insurers. Bupa uses its Code Search tool to allow recognised providers to look up procedure codes, descriptions, and applicable fee information. AXA Health publishes chapter-level fee information through its specialist procedure code portal. For Allianz Care UK, the published fee schedule is explicitly described as “based upon the industry-standard CCSD codes,” confirming T8700’s coverage. Always obtain written pre-authorisation and record the reference number before proceeding with any T8700 procedure.

Documentation Requirements for Lymph Node Excision Biopsy

Inadequate documentation is the primary driver of post-submission queries and payment delays for surgical biopsy codes. Insurers reviewing T8700 claims typically expect a clinical record that establishes why the procedure was necessary, what was done, and what the outcome was. This is not just good practice: it is a requirement for sustained recognition under Care Quality Commission requirements and under UK GDPR data retention obligations for patient records.

The following documentation should be present in the patient record before submitting a T8700 claim:

• Referral letter or GP/specialist correspondence confirming the clinical indication for excision biopsy
• Consultant’s pre-operative assessment documenting lymphadenopathy findings, duration, and previous investigations (including any FNA or imaging results)
• Operative note specifying the anatomical site (cervical, inguinal, or axillary), approach, and confirmation of intact node retrieval
• Histopathology request form sent alongside the excised specimen
• Post-operative note covering the patient’s immediate recovery and any complications
• Pre-authorisation reference number from the insurer, recorded in the patient’s administrative record

Clinics with paper-based records routinely encounter problems retrieving operative notes when insurers request supporting documentation. Switching to structured digital forms and electronic clinical notes ensures the full record is retrievable within seconds, which matters when an insurer audit arrives weeks after the procedure. For broader guidance on record standards, Pabau’s article on mandatory compliance requirements covers documentation obligations that apply across UK private practice settings.

UK GDPR, administered by the Information Commissioner’s Office (ICO), requires that patient records are retained for a minimum of eight years for adults. Surgical procedure records should be stored securely and be accessible for insurer audit requests during that period. Practices can review their obligations further using Pabau’s UK GDPR compliance checklist.

Streamline your CCSD claim submissions

Pabau's claims management software supports electronic CCSD code submission via Healthcode, structured operative note templates, and pre-authorisation tracking – all in one platform for UK private practices.

Book a demo

Submitting a CCSD Code T8700 Claim: Step-by-Step

Electronic submission through Healthcode is the standard route for most UK private insurer claims, including T8700. Healthcode acts as the UK’s electronic billing clearinghouse, routing claims from providers to insurers and returning remittances. Practices new to private practice management should register with Healthcode before seeing their first insured patient.

1. Obtain pre-authorisation from the patient’s insurer before the procedure. Record the reference number in the patient’s file. Confirm whether the authorisation covers surgeon fees only, or also anaesthetist and histopathology fees.
2. Complete the operative note on the day of surgery. Record the specific lymph node site (cervical, inguinal, or axillary) and confirm intact node excision. Vague operative notes (“lymph node removed”) increase the risk of insurer queries.
3. Code the claim using T8700. Confirm this is the correct code for the anatomical site treated. If additional procedures were performed in the same operating session, check the insurer’s bundling rules before adding additional CCSD codes.
4. Check anaesthetist fee billing separately. In most cases, the anaesthetist submits their own claim under the relevant CCSD anaesthetic code. Surgeons should not include anaesthetic fees in the T8700 claim unless there is a specific contractual arrangement to do so.
5. Submit electronically via Healthcode (or by the insurer’s required method). Include the pre-authorisation reference, patient membership number, and procedure date. Attach supporting documentation if the insurer’s portal allows it.
6. Track the claim status through your practice management system or Healthcode’s portal. Set a follow-up date for claims not acknowledged within 10 working days.

Practices using Pabau can submit CCSD claims directly via the integrated Healthcode connection, with claims management software that tracks submission status, outstanding remittances, and rejection reasons in one view. This removes the need to log into Healthcode separately for each claim.

Common Billing Errors and How to Avoid Them

Most T8700 claim problems fall into four categories. Understanding each one reduces the likelihood of post-submission queries, partial payments, or outright denials. Practices looking to strengthen their overall approach to leaving the NHS for private practice should build these checks into their billing workflow from day one.

• Missing pre-authorisation reference. The most common single cause of claim rejection. Every insurer requires a valid authorisation reference. Without it, the claim will not process. Obtain authorisation before the procedure date and confirm it covers the specific CCSD code T8700.
• Wrong anatomical site coded. T8700 covers only cervical, inguinal, and axillary lymph nodes. Billing T8700 for a mediastinal or other site is an incorrect code application. Check the operative note against the code definition before submission.
• Incorrect bundling of anaesthetic fees. Anaesthetic charges for lymph node excision biopsy are almost always billed by the anaesthetist separately. Including them in the surgeon’s T8700 claim creates a duplicate billing issue and triggers insurer queries.
• Submitting without histopathology documentation. The purpose of T8700 is diagnostic – insurers may query claims where there is no corresponding histopathology request, as it raises questions about whether the excision was performed for diagnostic purposes as coded.

The CCSD schedule is updated regularly. Code descriptions, bundling rules, and insurer-specific fee arrangements can change between schedule revisions. Providers should subscribe to the CCSD Group’s bulletin notifications and review the CCSD Technical Guide whenever a new version is released. The Allianz Care UK fee schedule and the Healix fee schedule both publish unbundling guidance that applies to surgical procedure codes including T8700.

Related CCSD Codes to Know

T8700 is one of several CCSD codes relevant to lymph node investigation and surgical oncology workflows. Knowing the adjacent codes reduces the risk of mis-coding and helps billers select the correct code when procedures differ slightly from T8700’s definition. Pabau’s CCSD procedure codes hub lists additional related codes for UK private healthcare providers.

When a procedure involves excision of a lymph node at a site not covered by T8700 (e.g. mediastinal or abdominal), an alternative CCSD code applies. The CCSD Technical Guide contains the full code list with descriptions. Always refer to the current schedule rather than relying on historical code references, as descriptions and chapter assignments are revised periodically. For broader private practice administration guidance, Pabau’s resource on medical forms workflow covers how structured documentation supports clean claim submission across all procedure types.

Expert Picks

Need a complete overview of CCSD billing for UK private practices? Bupa CCSD Codes: Complete Guide for UK Clinics covers code lookup, claim submission, and common billing pitfalls across the full CCSD schedule.

Looking to manage UK private healthcare claims electronically? Claims Management Software provides an integrated Healthcode submission workflow, claim tracking, and rejection management in one platform.

Need structured digital documentation for surgical procedures? Digital Forms enables operative notes, consent records, and pre-authorisation tracking to be stored and retrieved instantly for insurer audit requests.

Conclusion

Clean T8700 claims depend on three things getting right before the claim is submitted: confirmed pre-authorisation with a recorded reference number, a clear operative note specifying the anatomical site, and an understanding of each insurer’s bundling rules. Coding errors are rarely the cause of T8700 rejections; documentation and process gaps are.

Pabau’s claims management software supports UK private practices with integrated Healthcode submission, pre-authorisation tracking, and structured operative records – reducing the administrative burden on billing teams and helping practices maintain clean claim rates. To see how Pabau handles CCSD billing workflows in practice, book a demo.

Frequently Asked Questions